TAER-TAB
Tumor Associated Essential Receptor Targeting Antibody

High Rate of Mutations in Cancers Results in Patients that are Drug Resistant or Refractory​

Huge Unmet Needs in Oncology

Multifunctional Antibody Platform Technology

NUMBER OF MUTATIONS PER TUMOR

OUR SOLUTION

TAER-TAB is a platform technology that can be used to create multifunctional antibodies directed against multiple receptor targets on cancer cells. Multifunctional antibodies, such as Bispecifics, provide the dual benefits of Targeted Therapy and Immune Therapy.

Pinetree Therapeutics
West Cambridge Scientific Park
767C Concord Ave
Cambridge MA 02138

​Website designed by Creative Eye Design